Market Overview

Akumin Inc. Announces Second Quarter Fiscal 2018 Financial Results


Akumin Inc. Announces Second Quarter Fiscal 2018 Financial Results

Canada NewsWire

TORONTO, Aug. 13, 2018 /CNW/ - Akumin Inc. (TSX:AKU) ("Akumin" or the "Corporation") announced today its financial results for the quarter ended June 30, 2018 ("Q2 Fiscal 2018").  

Summary Consolidated Financial Results (in thousands, except for per share amounts)

period ended
Jun. 30, 2018

period ended
Jun. 30, 2017

period ended
Jun. 30, 2018

period ended
Jun. 30, 2017











Adjusted EBITDA (1)





Net Income (loss) attributable to common shareholders





Basic and diluted earnings (loss) per share





(1) See "Non-IFRS Measures" below.


Please note that the Corporation's condensed interim consolidated financial statements for Q2 Fiscal 2018 and related management's discussion and analysis are available under Akumin's profile on SEDAR (

Commenting on the Q2 Fiscal 2018 financial results, Riadh Zine, President and Chief Executive Officer of the Corporation, said,

"June quarter 2018 represents another fiscal quarter of solid financial performance, with an adjusted EBITDA of $8.3 million. During Q2 Fiscal 2018, we continued to execute on our growth strategy, including a $35 million equity financing, acquisition of four centers in the Tampa, Florida area effective May 11, 2018, and the purchase of the outstanding non-controlling interests in seven of our existing Texas-based diagnostic Imaging Centers effective May 24, 2018. 

"Beginning in Fiscal 2018, the Company commenced the reporting of the volume of procedures performed in its diagnostic imaging centers based on relative-value units, or RVUs.  RVUs are a standardized measure of value used in the U.S. Medicare reimbursement formula for physician services.  In Q2 Fiscal 2018, Akumin's volume was approximately 756,000 RVUs, compared to 666,000 RVUs in Q1 Fiscal 2018.

"On August 1, 2018, we announced a potential acquisition in Florida, expected to add approximately $27.5 million in annual revenue.  The potential acquisition is subject to customary conditions as well as a financing condition – we look forward to closing the acquisition and continuing our growth trajectory." At the end of Q2 Fiscal 2018, the Corporation had a total of 78 diagnostic imaging facilities throughout the United States, compared to 74 as at December 31, 2017.

Unless otherwise indicated, all amounts are expressed in U.S. dollars. Certain metrics, including those expressed on an adjusted or comparable basis, are non-IFRS measures. See "Non-IFRS Measures" and "Selected Consolidated Financial Information" of this press release for further details.

About Akumin

Akumin is a leading provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States with a network of 78 owned and/or operated imaging centers located in Florida, Pennsylvania, Delaware, Texas, Illinois and Kansas. By combining our clinical expertise with the latest advances in technology and information systems, our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, minimizing the cost and amount of care for patients. Our imaging procedures include MRI, CT, positron emission tomography (PET), ultrasound, diagnostic radiology (X-ray), mammography, and other interventional procedures.

Non-IFRS Measures

This press release makes reference to certain non-IFRS measures. These non-IFRS measures are not recognized measures under the International Financial Reporting Standards ("IFRS") and do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these non-IFRS measures are provided as additional information to complement those IFRS measures by providing further understanding of our results of operations from management's perspective. Accordingly, these non-IFRS measures should not be considered in isolation nor as a substitute for analysis of our financial information reported under IFRS. We use non-IFRS financial measures, including "EBITDA", "Adjusted EBITDA" and "Adjusted EBITDA Margin". These non-IFRS measures are used to provide investors with supplemental measures of our operating performance and thus highlight trends in our core business that may not otherwise be apparent when relying solely on IFRS measures. We also believe that securities analysts, investors and other interested parties frequently use non-IFRS measures in the evaluation of issuers. Our management uses non-IFRS measures in order to facilitate operating performance comparisons from period to period, to prepare annual operating budgets and forecasts, and to determine components of management compensation. Definitions and reconciliations of non-IFRS measures to the relevant reported measures can be found in our Management's Discussion and Analysis dated August 10, 2018 available at

We define such non-IFRS measures as follows:

"EBITDA" means net income (loss) attributable to shareholders of the Corporation before interest expense (net), income tax expense (recovery) and depreciation and amortization.

"Adjusted EBITDA" means EBITDA as further adjusted for stock-based compensation, impairment of property and equipment, provisions for certain credit losses, gains (losses) in the period, settlement costs, provisions and public offering and acquisition-related costs.

"Adjusted EBITDA Margin" means Adjusted EBITDA divided by the total revenue in the period.

Forward-Looking Information

Certain information in this press release constitutes forward-looking information. In some cases, but not necessarily in all cases, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "targets", "expects" or "does not expect", "is expected", "an opportunity exists", "is positioned", "estimates", "intends", "assumes", "anticipates" or "does not anticipate" or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be achieved". In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management's expectations, estimates and projections regarding future events.

Forward-looking information is necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by Akumin as of the date of this press release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to the factors described in greater detail in the "Risk Factors" section of our Annual Information Form and Management's Discussion and Analysis, each dated March 29, 2018 available at These factors are not intended to represent a complete list of the factors that could affect Akumin; however, these factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward-looking statements contained in this press release are made as of the date of this press release, and Akumin expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

< Financial tables follow. >

Selected Consolidated Financial Information

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at


(in thousands)

Three-month period
Jun 30, 2018

Three-month period
Jun 30, 2017

Service fees – net of allowances and discounts



Other Revenue



Total revenue



Employee compensation



Reading fees



Rent and utilities



Third party services and professional fees






Medical supplies and other expenses



Depreciation and amortization



Stock-based compensation 



Interest expense



Impairment of property and equipment



Settlement costs



Acquisition related costs



1 MRK, INCY: The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Aw...
2 ROKU, INTC: Bulls And Bears Of The Week: Facebook, Intel, Netflix, Tesla...
3 GWPH: 'Exceeded Our Expectations': First Latin Americ...
4 PYPL: Tilson: PayPal's 'Highly Deceptive Practice...
5 ETFC, SPY: Why A Financial Transaction Tax Would Destro...
6 TSLA: Jury Clears Elon Musk In 'Pedo Guy&...
7 LFCOF, ELIXF: The Week In Cannabis: Brazil...